A dry swab-based direct RT-PCR technique of COVID-19 testing, developed by CSIR-Centre for Mobile and Molecular Biology (CCMB), Hyderabad, and permitted by ICMR can now be adopted in testing labs of the nation. The tactic is simpler to hold out than the present procedures, and might ramp up testing by two three fold utilizing the present infrastructure within the testing labs.
The tactic wants no viral transport medium for sending samples from assortment centres to testing centres and requires a lot lesser pattern packing with no contamination amongst samples. On this technique, the RNA isolation steps have been changed by a single-step addition of an simply obtainable reagent.
Extract from this step could be immediately used for RT-PCR with out compromising on the standard of outcomes. It makes the checks quicker, cheaper and safer for healthcare staff, and enhance throughput with current sources and setup. The know-how has been licensed to numerous healthcare firms equivalent to Apollo Hospitals, Meril Life, Spice Well being and Capital Well being Pvt Ltd to fabricate and commercialise these testing kits. Many different business companions are anticipated to return on board quickly.
“India is fighting a steep surge in COVID-19 circumstances. The testing centres are overwhelmed with a variety of samples that should be examined. There’s an absolute want to extend our testing capability inside the current setup. We’re constructive that the dry swab-based direct RT-PCR technique will assist in the trigger immensely,” mentioned CCMB Advisor Dr Rakesh Mishra.
CCMB has supplied to coach workers of ICMR-approved authorities and personal testing centres to assist them undertake this technique. It goals to coach 500 testing centres throughout India, beginning this week. Most of those periods might be on-line to achieve out to centres out of Hyderabad.